ASRS
GBT

Arizona State Retirement System’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Arizona State Retirement System’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,806
Closed -$1.14M – 2299
2022
Q3 		$1.14M Buy
16,806
+118
+0.7% +$6.51K 0.01% 861
2022
Q2 		$533K Buy
16,688
+1,010
+6% +$29.6K 0.01% 1316
2022
Q1 		$543K Buy
15,678
+560
+4% +$16.7K ﹤0.01% 1415
2021
Q4 		$443K Sell
15,118
-147
-1% -$4.55K ﹤0.01% 1609
2021
Q3 		$389K Buy
15,265
+59
+0.4% +$1.73K ﹤0.01% 1679
2021
Q2 		$533K Sell
15,206
-984
-6% -$38.4K ﹤0.01% 1536
2021
Q1 		$660K Buy
16,190
+174
+1% +$8K 0.01% 1389
2020
Q4 		$694K Sell
16,016
-533
-3% -$26.3K 0.01% 1281
2020
Q3 		$913K Buy
16,549
+4,192
+34% +$266K 0.01% 969
2020
Q2 		$780K Sell
12,357
-1,783
-13% -$122K 0.01% 889
2020
Q1 		$722K Buy
+14,140
New +$947K 0.01% 808

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Arizona State Retirement System's GBT Position: Q4 2022 in Review

Arizona State Retirement System sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 16,806 shares — an estimated $1.14M sold.

Arizona State Retirement System first reported a position in GBT in Q1 2020 and held it in 11 quarters. The position peaked at $1.14M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Arizona State Retirement System reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Arizona State Retirement System sold 16,806 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.14M.
  • Arizona State Retirement System first reported a position in Global Blood Therapeutics, Inc. in Q1 2020 and held it in 11 quarters.
  • Arizona State Retirement System's Global Blood Therapeutics, Inc. position peaked at $1.14M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Arizona State Retirement System's 13F filing for Q4 2022, filed 8 Feb 2023.